FDA’s refusal to review Moderna’s mRNA flu vaccine
Digest more
"The FDA rejected Moderna's application for filing because the company refused to follow very clear FDA guidance from 2024 to ...
The US pharma firm’s 40,000-person study suggested its new shot was more effective than a standard flu vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results